Detact Diagnostics Receives Grants to Develop POC Tests
Detact Diagnostics has received $5.9M in grants from the Bill & Melinda Gates Foundation to develop point-of-care diagnostic tests.
Read MorePosted by Chris Wolski | Dec 26, 2024 | POC Reagents & Test Kits |
Detact Diagnostics has received $5.9M in grants from the Bill & Melinda Gates Foundation to develop point-of-care diagnostic tests.
Read MorePosted by Andy Lundin | Dec 17, 2024 | Point-of-Care |
A new nanobody-based immunosensor is capable of stable operation in undiluted biological fluids with promising applications in POC testing.
Read MorePosted by Andy Lundin | Dec 17, 2024 | Emerging & Zoonotic Diseases, Point-of-Care |
Labcorp introduced a molecular H5 bird flu test to help diagnose human infections with the H5N1 virus, enhancing public health response.
Read MorePosted by Andy Lundin | Dec 5, 2024 | Mass Spectrometry |
A new mass spectrometry technique quickly and non-invasively assesses paracetamol levels from a single drop of saliva.
Read MorePosted by Chris Wolski | Nov 29, 2024 | Immunoassay |
A graphene-based biosensor with a molecular carbon intermediate layer has been developed to detect specific biomarkers.
Read More